Increased levels of Osteopontin in sputum supernatant in patients with COPD

Chest

Volumn 146, Issue 4, 2014, Pages 951-958

  Papaporfyriou, Anastasia ^a   Loukides, Stelios ^c   Kostikas, Konstantinos ^c   Simoes, Davina C M ^a   Papatheodorou, Georgios ^d   Konstantellou, Elissavet ^a   Hillas, Georgios ^b   Papiris, Spyros ^c   Koulouris, Nikolaos ^a   Bakakos, Petros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Department of Respiratory and Critical Care Medicine Research Unit Sotiria Chest Hospital   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

^d 401 Military Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; GELATINASE A; INTERLEUKIN 8; LEUKOTRIENE B4; OSTEOPONTIN; TIOTROPIUM BROMIDE; TRANSFORMING GROWTH FACTOR BETA1; IL8 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN;

ARTICLE; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFLAMMATORY CELL; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MEDIATOR RELEASE; NEUTROPHIL COUNT; OPEN STUDY; PATHOGENESIS; PROTEIN ANALYSIS; SMOKING; SPUTUM ANALYSIS; SPUTUM LEVEL; SUPERNATANT; AGED; EMPHYSEMA; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SPUTUM;

AGED; EMPHYSEMA; FEMALE; HUMANS; INTERLEUKIN-8; LEUKOTRIENE B4; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; OSTEOPONTIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPUTUM; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84907942144     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2440     Document Type: Article

References (28)

1. Jeffery PK . Remodeling in asthma and chronic obstructive lung disease . Am J Respir Crit Care Med . 2001; 164 ( 10 pt 2 ): S28 - S38 .
2. Zhou Y, Murthy JN, Zeng D, Belardinelli L, Blackburn MR . Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis . PLoS ONE . 2010; 5 ( 2 ): e9224 .
3. Sun CX, Zhong H, Mohsenin A, et al . Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury . J Clin Invest . 2006; 116 ( 8 ): 2173 - 2182 .
4. Schneider DJ, Lindsay JC, Zhou Y, Molina JG, Blackburn MR . Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease . FASEB J . 2010; 24 ( 1 ): 70 - 80 .
5. Hillas G, Loukides S, Kostikas K, et al . Increased levels of osteopontin in sputum supernatant of smoking asthmatics . Cytokine . 2013; 61 ( 1 ): 251 - 255 .
6. Delimpoura V, Bakakos P, Tseliou E, et al . Increased levels of osteopontin in sputum supernatant in severe refractory asthma . Thorax . 2010; 65 ( 9 ): 782 - 786 .
7. Vestbo J, Hurd SS, Agustí AG, et al . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary . Am J Respir Crit Care Med . 2013; 187 ( 4 ): 347 - 365 .
8. Kips JC, Fahy JV, Hargreave FE, Ind PW, in't Veen JC . Methods for sputum induction and analysis of induced sputum: A method for assessing airway inflammation in asthma . Eur Respir J Suppl . 1998; 26 : 9S - 12S .
9. Efthimiadis A, Spanevello A, Hamid Q, et al . Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation . Eur Respir J Suppl . 2002; 37 : 19s - 23s .
10. American Thoracic Society . Standardization of spirometry, 1994 update . Am J Respir Crit Care Med . 1995; 152 ( 3 ): 1107 - 1136 .
11. Cazzola M, MacNee W, Martinez FJ, et al; American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD . Outcomes for COPD pharmacological trials: from lung function to biomarkers . Eur Respir J . 2008; 31 ( 2 ): 416 - 469 .
12. Park KJ, Bergin CJ, Clausen JL . Quantitation of emphysema with threedimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results . Radiology . 1999; 211 ( 2 ): 541 - 547 .
13. Boschetto P, Quintavalle S, Zeni E, et al . Association between markers of emphysema and more severe chronic obstructive pulmonary disease . Thorax . 2006; 61 ( 12 ): 1037 - 1042 .
14. Woodruff PG, Koth LL, Yang YH, et al . A distinctive alveolar macrophage activation state induced by cigarette smoking . Am J Respir Crit Care Med . 2005; 172 ( 11 ): 1383 - 1392 .
15. Prasse A, Stahl M, Schulz G, et al . Essential role of osteopontin in smokingrelated interstitial lung diseases . Am J Pathol . 2009; 174 ( 5 ): 1683 - 1691 .
16. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS . Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival . J Clin Invest . 2001; 107 ( 9 ): 1055 - 1061 .
17. Berman JS, Serlin D, Li X, et al . Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice . Am J Physiol Lung Cell Mol Physiol . 2004; 286 ( 6 ): L1311 - L1318 .
18. Derynck R, Akhurst RJ, Balmain A . TGF-beta signaling in tumor suppression and cancer progression . Nat Genet . 2001; 29 ( 2 ): 117 - 129 .
19. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis . Genes Dev . 2000; 14 ( 2 ): 163 - 176 .
20. Wu L, Chau J, Young RP, et al . Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease . Thorax . 2004; 59 ( 2 ): 126 - 129 .
21. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT . Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema . Lab Invest . 1998; 78 ( 9 ): 1077 - 1087 .
22. Baraldo S, Bazzan E, Zanin ME, et al . Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression . Chest . 2007; 132 ( 6 ): 1733 - 1740 .
23. Cataldo D, Munaut C, Noël A, et al . MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease . Int Arch Allergy Immunol . 2000; 123 ( 3 ): 259 - 267 .
24. Ziora D, Dworniczak S, Kozielski J . Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease . J Physiol Pharmacol . 2008; 59 ( suppl 6 ): 809 - 817 .
25. Shan M, Yuan X, Song LZ et al. Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 2012;4(117):117ra9.
26. Yoshikawa T, Dent G, Ward J, et al . Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 2007; 175 ( 5 ): 473 - 479 .
27. Koh A, da Silva AP, Bansal AK, et al. Role of osteopontin in neutrophil function . Immunology . 2007; 122 ( 4 ): 466 - 475 .
28. Turato G, Zuin R, Miniati M, et al . Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema . Am J Respir Crit Care Med . 2002; 166 ( 1 ): 105 - 110 .